Cargando…

Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis

Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by chronic inflammation and progressive fibrosis of the biliary tree. The majority of PSC patients suffer from concomitant inflammatory bowel disease (IBD), which has been suggested to promote disease developme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gui, Wenfang, Hole, Mikal Jacob, Molinaro, Antonio, Edlund, Karolina, Jørgensen, Kristin K., Su, Huan, Begher-Tibbe, Brigitte, Gaßler, Nikolaus, Schneider, Carolin V., Muthukumarasamy, Uthayakumar, Mohs, Antje, Liao, Lijun, Jaeger, Julius, Mertens, Christian J., Bergheim, Ina, Strowig, Till, Hengstler, Jan G., Hov, Johannes R., Marschall, Hanns-Ulrich, Trautwein, Christian, Schneider, Kai Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244448/ https://www.ncbi.nlm.nih.gov/pubmed/37280200 http://dx.doi.org/10.1038/s41467-023-38840-8

Ejemplares similares

Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment
por: Schneider, Kai Markus, et al.
Publicado: (2022)

Intestinal Microbiota Protects against MCD Diet-Induced Steatohepatitis
por: Schneider, Kai Markus, et al.
Publicado: (2019)

Microbiota of vaccinated and non-vaccinated clinically inconspicuous and conspicuous piglets under natural Lawsonia intracellularis infection
por: Hankel, Julia, et al.
Publicado: (2022)

Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitis
por: Braadland, Peder Rustøen, et al.
Publicado: (2022)

Epidermal growth factor signaling protects from cholestatic liver injury and fibrosis
por: Svinka, Jasmin, et al.
Publicado: (2016)

Ileal Bile Acid Transporter Inhibition for the Treatment of Chronic Constipation, Cholestatic Pruritus, and NASH
por: Al-Dury, Samer, et al.
Publicado: (2018)

Intestinal Dysbiosis Amplifies Acetaminophen-Induced Acute Liver Injury
por: Schneider, Kai Markus, et al.
Publicado: (2020)

Variant adiponutrin confers genetic protection against cholestatic itch
por: Krawczyk, Marcin, et al.
Publicado: (2014)

Digital twin demonstrates significance of biomechanical growth control in liver regeneration after partial hepatectomy
por: Hoehme, Stefan, et al.
Publicado: (2022)

High Dietary Intake of Rye Affects Porcine Gut Microbiota in a Salmonella Typhimurium Infection Study
por: Hankel, Julia, et al.
Publicado: (2022)

Transcriptomic Cross‐Species Analysis of Chronic Liver Disease Reveals Consistent Regulation Between Humans and Mice
por: Holland, Christian H., et al.
Publicado: (2021)

Hepatocyte specific expression of an oncogenic variant of β-catenin results in cholestatic liver disease
por: Lemberger, Ursula J., et al.
Publicado: (2016)

Pilot study with IBAT inhibitor A4250 for the treatment of cholestatic pruritus in primary biliary cholangitis
por: Al-Dury, Samer, et al.
Publicado: (2018)

Why Doesn’t Primary Biliary Cholangitis Respond to Immunosuppressive Medications?
por: Molinaro, Antonio, et al.
Publicado: (2017)

Application of magnetic resonance imaging in transgenic and chemical mouse models of hepatocellular carcinoma
por: Freimuth, Julia, et al.
Publicado: (2010)

Interleukin-8 Is Activated in Patients with Chronic Liver Diseases and Associated with Hepatic Macrophage Accumulation in Human Liver Fibrosis
por: Zimmermann, Henning W., et al.
Publicado: (2011)

Automated Detection of Portal Fields and Central Veins in Whole-Slide Images of Liver Tissue
por: Budelmann, Daniel, et al.
Publicado: (2022)

JNKs protect from cholestatic liver disease progression by modulating Apelin signalling
por: Mohamed, Mohamed Ramadan, et al.
Publicado: (2023)

Reduced intestinal lipid absorption improves glucose metabolism in aged G2-Terc knockout mice
por: Liu, Xue, et al.
Publicado: (2023)

Removable denture is a risk indicator for peri-implantitis and facilitates expansion of specific periodontopathogens: a cross-sectional study
por: Grischke, Jasmin, et al.
Publicado: (2021)

Successful Fecal Microbiota Transplantation in a Patient with Severe Complicated Clostridium difficile Infection after Liver Transplantation
por: Schneider, Kai Markus, et al.
Publicado: (2018)

Ursodeoxycholic acid enriches intestinal bile salt hydrolase-expressing Bacteroidetes in cholestatic pregnancy
por: Ovadia, Caroline, et al.
Publicado: (2020)

Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2(−/−) mouse model of sclerosing cholangitis via immunomodulatory effects
por: Fuchs, Claudia D., et al.
Publicado: (2022)

Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2(−/−) mice by modulating composition, signalling and excretion of faecal bile acids
por: Fuchs, Claudia Daniela, et al.
Publicado: (2018)

Pharmacological Inhibition of the Chemokine CXCL16 Diminishes Liver Macrophage Infiltration and Steatohepatitis in Chronic Hepatic Injury
por: Wehr, Alexander, et al.
Publicado: (2014)

Intrahepatic Cholestasis of Pregnancy Levels of Sulfated Progesterone Metabolites Inhibit Farnesoid X Receptor Resulting in a Cholestatic Phenotype
por: Abu-Hayyeh, Shadi, et al.
Publicado: (2013)

Single-Nucleotide Polymorphism-Based Genetic Diversity Analysis of Clinical Pseudomonas aeruginosa Isolates
por: Muthukumarasamy, Uthayakumar, et al.
Publicado: (2020)

Differential Role of gp130-Dependent STAT and Ras Signalling for Haematopoiesis Following Bone-Marrow Transplantation
por: Kroy, Daniela C., et al.
Publicado: (2012)

Hepatobiliary Thyroid Hormone Deficiency Impacts Bile Acid Hydrophilicity and Aquaporins in Cholestatic C57BL/6J Mice
por: Kube, Irina, et al.
Publicado: (2022)

Variation in Bile Microbiome by the Etiology of Cholestatic Liver Disease
por: Tyc, Olaf, et al.
Publicado: (2020)

Paneth cells in intestinal physiology and pathophysiology
por: Gassler, Nikolaus
Publicado: (2017)

ACSL4-dependent ferroptosis does not represent a tumor-suppressive mechanism but ACSL4 rather promotes liver cancer progression
por: Grube, Julia, et al.
Publicado: (2022)

Cyclin E1 in Murine and Human Liver Cancer: A Promising Target for Therapeutic Intervention during Tumour Progression
por: Sonntag, Roland, et al.
Publicado: (2021)

Cholestatic hepatitis with intravenous ceftriaxone
por: Kaur, Inderpal, et al.
Publicado: (2011)

Azathioprine induced cholestatic hepatitis
por: Moses, Viju, et al.
Publicado: (2011)

Trifluoperazine-Induced Cholestatic Jaundice
por: Sharifi, Vandad, et al.
Publicado: (2010)

Cephalexin Induced Cholestatic Jaundice
por: Agrawal, Abhinav, et al.
Publicado: (2014)

Azithromycin-induced cholestatic hepatitis
por: Koffas, Apostolos, et al.
Publicado: (2017)

Current Therapies for Cholestatic Diseases
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2023)

The Genetics of Inherited Cholestatic Disorders in Neonates and Infants: Evolving Challenges
por: Jeyaraj, Rebecca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_950k53dssgcmnf74avphdii5a5